Key result
Neonates with enterovirus infections had a higher risk of death compared to infected persons aged ≥1 month.
Why the study?
What are the common enterovirus serotypes and their association with fatal outcomes in neonates compared to older individuals?
Observational (n=26,737)
Yes
What are the common enterovirus serotypes and their association with fatal outcomes in neonates compared to older individuals?
Neonatal enterovirus infections, particularly with coxsackievirus B4, are associated with a significantly higher risk of death compared to infections in older individuals.
Answers are grounded in this paper and cite their sources.
Neonates with enterovirus warrant close monitoring; this cohort study leaves open serotype-specific fatality risks.
BACKGROUND: Neonatal enterovirus (EV) infections lead to a wide range of clinical manifestations, from mild febrile illness to severe, sometimes fatal, sepsislike disease. METHODS: To determine the relationship of EV serotypes with the risk of neonatal infection and its fatal outcome, we analyzed data reported to the National Enterovirus Surveillance System (NESS) during 1983-2003. RESULTS: Of the 26,737 EV detections reported during this period, neonates accounted for 2544 (11.4% of those with known age). Serotypes most commonly isolated from neonates included echovirus (E) 11 (14.0% of EV with known serotype), coxsackievirus (CV) B2 (8.9%), CVB5 (7.5%), E6, E9 and CVB4 (6.8% each). CVB1-4, E11, and E25 were significantly more common, whereas CVA16, E4, E9, E21, E30, and human parechovirus 1 (formerly E22) were less common among neonates than among persons aged > or =1 month. Fatal outcome was noted for 3.3% of reports, with neonates at a higher risk of death than persons aged > or =1 month (11.5% versus 2.5%; odds ratio [OR] 5.1; 95% confidence interval [CI] = 3.3-7.8). Neonates infected with CVB4 were at a higher risk of death (OR 6.5; 95% CI = 2.4-17.7) than those infected with other EV. CONCLUSION: EV are important neonatal pathogens associated with high risk of infection and death. Because of the limitations of the NESS (incomplete reporting, limited clinical data, bias towards more severe and younger cases), additional studies are needed to better evaluate the role of different EV in neonatal infections.
No takes yet. Share an insight, caveat, or question.
Khetsuriani et al. (2006) conducted an observational in Enterovirus infections (n=26,737). Neonatal age vs. Age ≥1 month was evaluated on Fatal outcome (OR 5.1, 95% CI 3.3-7.8). Neonates with enterovirus infections had a higher risk of death compared to infected persons aged ≥1 month.
Synapse has enriched 10 related papers. Consider them for comparative context: